Stock comparison
Merck & Co., Inc. is 35.0x more valuable than Crinetics Pharmaceuticals, Inc. by market capitalization ($308.90 B vs $8.82 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MRK is larger
Merck & Co., Inc. is 35.0x more valuable than Crinetics Pharmaceuticals, Inc. by market capitalization ($308.90 B vs $8.82 B).
Market value leader
MRK
Merck & Co., Inc. is 35.0x more valuable than Crinetics Pharmaceuticals, Inc. by market capitalization ($308.90 B vs $8.82 B).
Revenue leader
MRK
CRNX: $7.70M vs MRK: $65.01B.
Profit leader
MRK
CRNX: -$465.30M vs MRK: $18.25B.
Margin leader
MRK
CRNX: -6046.0% vs MRK: 28.1% net margin.
| Metric | CRNX | MRK |
|---|---|---|
| Market cap | $8.82 B | $308.90 B |
| US-listed rank | #1035 | #45 |
| Revenue (latest FY) | $7.70M | $65.01B |
| Net income (latest FY) | -$465.30M | $18.25B |
| Net margin | -6046.0% | 28.1% |
| P/E (trailing FY) | - | 16.9x |
| SEC filings | 670 | 998 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Merck & Co., Inc. is 35.0x more valuable than Crinetics Pharmaceuticals, Inc. by market capitalization ($308.90 B vs $8.82 B).
In their latest fiscal years, Crinetics Pharmaceuticals, Inc. reported $7.70M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: Crinetics Pharmaceuticals, Inc. and Merck & Co., Inc., or browse the full rankings.